Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,084.35
+13.45 (1.26%)
At close: Jun 22, 2026
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.09 trillion as of June 22, 2026. Its market cap has increased by 16.97% in one year.
Market Cap
1.09T
Enterprise Value
1.17T
Revenue
271.48B
Ranking
n/a
PE Ratio
21.67
Stock Price
1,084.35
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.09T, an increase of 13,227.18%. That is a compound annual growth rate of 22.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 1.09T | 18.72% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.50T |
| Lupin | 1.08T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 557.17B |
| GlaxoSmithKline Pharmaceuticals | 395.20B |
| J. B. Chemicals & Pharmaceuticals | 351.51B |
| Rubicon Research | 224.36B |
| AstraZeneca Pharma India | 210.17B |